Most FDA Scientists Opposed Plan to Ease Access to Unproven Peptide Drugs, Sources Say
Photo: The Guardian USA plan to give people in the United States easier access to unproven peptide drugs, which Health Secretary Robert F. Kennedy Jr. favors, was opposed by most scientific staff members at the Food and Drug Administration, according to six people familiar with how the policy was developed. The plan is an effort by President Donald Trump's administration to loosen rules on the drugs. The sources said the FDA scientists had limited input in drafting the policy.
The excerpts available describe the plan as a move by the Trump administration to ease access to peptides, which have not been proven through the usual FDA review process. Beyond the staff opposition and the limited input in drafting, the excerpts do not give details of the policy's text, its timing or what happens next.
The Washington Times, on the right, leads with the same news as the others: a plan favored by Kennedy that most FDA scientific staff opposed. Its excerpt speaks of giving "Americans" easier access, stresses the six people familiar with the policy's development, and notes the staff's limited input. Its headline calls the policy an "effort" by the administration. CNN and The Washington Post, on the left, run nearly identical headlines saying FDA scientists opposed the administration's move or effort. CNN's excerpt names Kennedy and the opposition of most scientific staff, while the Post's says scientists did not support an effort to loosen rules and does not mention Kennedy, the six sources or the limited input in its excerpt. The two sides agree on the central fact and on describing the drugs as unproven. The differences are small: the right-leaning excerpt carries the sourcing and limited-input detail in full, CNN names Kennedy and the staff majority, and the Post's excerpt is the most general. The alternative outlet, AP, closely matches the right-leaning wording and sourcing.
How the sides differ Right sources, like the others, report staff opposition with similar wording; left sources add little beyond the shared account, and alternative coverage matches the same sourcing and framing.
Headline, comparison and summary written by AI from the articles below. AI can make mistakes, so check the original articles before relying on a detail.
CNN and The Washington Post headline FDA scientists' opposition to the administration's effort. CNN's excerpt names Kennedy and says most scientific staff opposed the plan; the Post's excerpt is more general, citing scientists' lack of support.
AP leads with the plan favored by Kennedy and opposed by most FDA scientific staff, who had limited input, citing six people familiar with the matter.
The Washington Times leads with the plan Kennedy favors and most FDA scientific staff opposed, stressing their limited input in drafting and its six sources familiar with the policy's development.